A. Elkind

623 total citations
8 papers, 470 citations indexed

About

A. Elkind is a scholar working on Psychiatry and Mental health, Pathology and Forensic Medicine and Sensory Systems. According to data from OpenAlex, A. Elkind has authored 8 papers receiving a total of 470 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Psychiatry and Mental health, 4 papers in Pathology and Forensic Medicine and 2 papers in Sensory Systems. Recurrent topics in A. Elkind's work include Migraine and Headache Studies (8 papers), Trigeminal Neuralgia and Treatments (3 papers) and Sympathectomy and Hyperhidrosis Treatments (2 papers). A. Elkind is often cited by papers focused on Migraine and Headache Studies (8 papers), Trigeminal Neuralgia and Treatments (3 papers) and Sympathectomy and Hyperhidrosis Treatments (2 papers). A. Elkind collaborates with scholars based in United States, Germany and Belgium. A. Elkind's co-authors include Hartmut Göbel, Nabih M. Ramadan, James U. Adelman, N T Mathew, Mahnaz Asgharnejad, William S. Mullican, Alan M. Rapoport, Robert Ryan, David Kudrow and Nancy L. Earl and has published in prestigious journals such as Neurology, Headache The Journal of Head and Face Pain and Cephalalgia.

In The Last Decade

A. Elkind

8 papers receiving 422 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A. Elkind United States	7	399	269	262	66	41	8	470
Jayasree Kailasam United States	11	604 1.5×	405 1.5×	320 1.2×	82 1.2×	62 1.5×	11	647
Katja Heinze‐Kuhn Germany	11	277 0.7×	147 0.5×	160 0.6×	109 1.7×	23 0.6×	33	397
AJ Pilgrim United Kingdom	10	464 1.2×	326 1.2×	264 1.0×	22 0.3×	40 1.0×	11	528
IW Husstedt Germany	12	544 1.4×	320 1.2×	268 1.0×	155 2.3×	25 0.6×	21	616
A Prusiński Poland	11	461 1.2×	346 1.3×	280 1.1×	36 0.5×	20 0.5×	53	529
K. Roger Aoki United States	4	180 0.5×	122 0.5×	190 0.7×	196 3.0×	43 1.0×	6	385
TD Rozen United States	10	484 1.2×	323 1.2×	234 0.9×	95 1.4×	16 0.4×	12	573
C. Hedman Denmark	12	305 0.8×	175 0.7×	156 0.6×	22 0.3×	35 0.9×	21	438
Mathew Nt United States	7	279 0.7×	160 0.6×	138 0.5×	30 0.5×	28 0.7×	10	346
EJ Piovesan Brazil	8	305 0.8×	195 0.7×	115 0.4×	36 0.5×	17 0.4×	10	355

Countries citing papers authored by A. Elkind

Since Specialization

Citations

This map shows the geographic impact of A. Elkind's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Elkind with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Elkind more than expected).

Fields of papers citing papers by A. Elkind

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Elkind. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Elkind. The network helps show where A. Elkind may publish in the future.

Co-authorship network of co-authors of A. Elkind

This figure shows the co-authorship network connecting the top 25 collaborators of A. Elkind. A scholar is included among the top collaborators of A. Elkind based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Elkind. A. Elkind is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Schoenen, J, et al.. (2009). Tonabersat, a Gap-Junction Modulator: Efficacy and Safety in Two Randomized, Placebo-Controlled, Dose-Ranging Studies of Acute Migraineceph. Cephalalgia. 29(2_suppl). 17–27. 46 indexed citations

2.

Silberstein, SD, Hartmut Göbel, Rigmor Jensen, et al.. (2006). Botulinum Toxin Type A in the Prophylactic Treatment of Chronic Tension-Type Headache: A Multicentre, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study. Cephalalgia. 26(7). 790–800. 112 indexed citations

3.

Elkind, A., et al.. (1997). Twenty‐Four‐Hour Effectiveness of BMS 180048 in the Acute Treatment of Migraine Headaches. Headache The Journal of Head and Face Pain. 37(4). 245–248. 11 indexed citations

4.

Rapoport, Alan M., Nabih M. Ramadan, James U. Adelman, et al.. (1997). Optimizing the dose of zolmitriptan (Zomig,* 311C90) for the acute treatment of migraine. Neurology. 49(5). 1210–1218. 125 indexed citations

5.

Ryan, Robert, et al.. (1997). Sumatriptan nasal spray for the acute treatment of migraine. Neurology. 49(5). 1225–1230. 109 indexed citations

6.

Elkind, A., et al.. (1989). Efficacy of Guanfacine in a Double Blind Parallel Study for Migraine Prophylaxis. Cephalalgia. 9(10_suppl). 369–370. 4 indexed citations

7.

Sudilovsky, Abraham, et al.. (1987). Comparative Efficacy of Nadolol and Propranolol in the Management of Migraine. Headache The Journal of Head and Face Pain. 27(8). 421–426. 25 indexed citations

8.

Elkind, A., A P Friedman, & Jay Grossman. (1964). Cutaneous blood flow in vascular headaches of the migraine type. Neurology. 14(1). 24–24. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact